Li Li
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
Papers in
-
- Histone Deacetylase Inhibitors Research 20
- Cell death mechanisms and regulation 20
- Oncology 69
- HER2/EGFR in Cancer Research 20
- Co-authors
- Wenqiang Wei (3 shared papers)Rongshou Zheng (3 shared papers)Hongmei Zeng (3 shared papers)Jie He (2 shared papers)Siwei Zhang (2 shared papers)Ru Chen (2 shared papers)Shaoming Wang (1 shared paper)Kexin Sun (1 shared paper)
- Journals
- Blood (11 papers)PLoS ONE (9 papers)Oncotarget (7 papers)BMC Cancer (6 papers)Journal of Medicinal Chemistry (5 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Li Li
408 papers receiving 10.0k citations
Li Li's Hit Papers
Peers
Comparison fields: 5 of 169
- Cancer Research 1.2k
- Oncology 1.7k
- Molecular Biology 4.3k
- Genetics 618
- Geriatrics and Gerontology 182
Countries citing papers authored by Li Li
This map shows the geographic impact of Li Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Li more than expected).
Fields of papers citing papers by Li Li
This network shows the impact of papers produced by Li Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Li. The network helps show where Li Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 421 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer incidence and mortality in China, 2016 Hit paper breakdown → | 2022 | 1043 |
| 2 | 2008 | 322 | |
| 3 | 2009 | 232 | |
| 4 | 2016 | 225 | |
| 5 | 2000 | 164 | |
| 6 | 2018 | 142 | |
| 7 | 2015 | 137 | |
| 8 | 2015 | 126 | |
| 9 | 2010 | 122 | |
| 10 | 2016 | 121 | |
| 11 | 2020 | 112 | |
| 12 | 2004 | 105 | |
| 13 | 2002 | 100 | |
| 14 | 2015 | 100 | |
| 15 | 2018 | 99 | |
| 16 | 2015 | 99 | |
| 17 | 2012 | 98 | |
| 18 | 2014 | 92 | |
| 19 | 2018 | 86 | |
| 20 | 2002 | 86 |
About Li Li
Li Li is a scholar working on Molecular Biology, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Genetics, having authored 421 papers that have together received 10.2k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (48 papers), Chronic Lymphocytic Leukemia Research (22 papers), HER2/EGFR in Cancer Research (20 papers), Histone Deacetylase Inhibitors Research (20 papers), Cell death mechanisms and regulation (20 papers), Lung Cancer Treatments and Mutations (17 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Nuclear Receptors and Signaling (13 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.7k citations), Molecular Biology (4.3k citations), Genetics (618 citations) and Geriatrics and Gerontology (182 citations). Li Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Wenqiang Wei, Rongshou Zheng, Hongmei Zeng, Jie He, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Kang Moo Huh and Ping Qiu. Their work appears in journals such as Blood, PLoS ONE, Oncotarget, BMC Cancer and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.